Robert Taylor

Robert Taylor is a highly experienced professional in the field of molecular biology and drug metabolism. Currently serving as the Global Director and Technical Sales Specialist for ADMET at BioIVT since January 2018, Robert previously held the position of Director of Research and Development at Spot On Sciences, focusing on blood-based biomarkers related to cardiovascular disease. With a strong background in enzyme mechanistic studies, Robert worked as a Principal Scientist at Roche Pharmaceuticals, leading the early ADME Mechanistic Enzymology group. Prior to this, Robert held director roles at CellzDirect and Invitrogen, where Robert managed and directed various drug metabolism studies. Robert holds a Ph.D. in Molecular Toxicology from UCLA and a BS in Biochemistry from the University of California, Davis.